Maravai LifeSciences Holdings (MEX:MRVI) Other Current Liabilities: MXN0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:MRVI Maravai LifeSciences Holdings Inc MEX:MRVI
56 GF Score
Price MXN85.00
GF Value MXN44.85
! 8 Warning Signs
View Full Analysis

What is Maravai LifeSciences Holdings Other Current Liabilities?

Maravai LifeSciences Holdings MEX:MRVI 56 Other Current Liabilities is MXN0 Mil as of Mar. 2026. GuruFocus rates MEX:MRVI with a GF Score™ of 56/100 and a GF Value™ of MXN44.85. The stock has 8 warning signs investors should review.

Maravai LifeSciences Holdings's other current liabilities for the quarter that ended in Mar. 2026 was MXN0 Mil.

Maravai LifeSciences Holdings's quarterly other current liabilities declined from Sep. 2025 (MXN266 Mil) to Dec. 2025 (MXN234 Mil) and declined from Dec. 2025 (MXN234 Mil) to Mar. 2026 (MXN0 Mil).

Maravai LifeSciences Holdings's annual other current liabilities increased from Dec. 2023 (MXN270 Mil) to Dec. 2024 (MXN390 Mil) but then declined from Dec. 2024 (MXN390 Mil) to Dec. 2025 (MXN234 Mil).

Maravai LifeSciences Holdings Other Current Liabilities Related Terms

Maravai LifeSciences Holdings Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Maravai LifeSciences Holdings's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Maravai LifeSciences Holdings Other Current Liabilities Chart

Maravai LifeSciences Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial 387.59 582.40 270.38 390.13 234.07

Maravai LifeSciences Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 0.00 266.05 234.07 0.00
MEX:MRVI
56GF Score
Maravai LifeSciences Holdings Inc MEX:MRVI
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Maravai LifeSciences Holdings Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of MXN0 Mil mean?
Maravai LifeSciences Holdings (MEX:MRVI) has a Other Current Liabilities of MXN0 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Maravai LifeSciences Holdings.
Is Maravai LifeSciences Holdings' Other Current Liabilities too high?
Maravai LifeSciences Holdings' current Other Current Liabilities is MXN0 Mil. Overall, Maravai LifeSciences Holdings has a GF Score™ of 56/100, reflecting its overall financial health beyond just this single metric.
How does Maravai LifeSciences Holdings' Other Current Liabilities compare to LBRX and SLDB?
Maravai LifeSciences Holdings' Other Current Liabilities of MXN0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Maravai LifeSciences Holdings. Maravai LifeSciences Holdings's current Other Current Liabilities is MXN0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maravai LifeSciences Holdings stock overvalued right now?
Maravai LifeSciences Holdings (MEX:MRVI) has a current Other Current Liabilities of MXN0 Mil. The stock's GF Value™ is MXN44.85, compared to a current price of MXN85.00 — trading 89.5% above its estimated fair value. The current Other Current Liabilities is MXN0 Mil. Maravai LifeSciences Holdings' overall GF Score™ is 56/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Maravai LifeSciences Holdings (MEX:MRVI), the current Other Current Liabilities is MXN0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Maravai LifeSciences Holdings (MEX:MRVI) Overvalued in 2026?

Based on GuruFocus' analysis, Maravai LifeSciences Holdings stock appears to be overvalued. The current stock price of MXN85.00 is trading 89.5% above its estimated GF Value™ of MXN44.85.

Key valuation signals for MEX:MRVI:

  • Other Current Liabilities: MXN0 Mil
  • GF Value™: MXN44.85 vs. price of MXN85.00 (89.5% above fair value)
  • GF Score™: 56/100 with 8 warning signs

No single metric tells the full story. See the MEX:MRVI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Maravai LifeSciences Holdings Business Description

Other Exchanges MRVI:USAMAR:Germany
Address 10770 Wateridge Circle, Suite 200, San Diego, CA, USA, 92121
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
56GF Score

Get the complete analysis for MEX:MRVI

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN85.00
Price
MXN44.85
GF Value